Singapore markets open in 4 hours 30 minutes
Straits Times Index
3,290.70 -2.23 (-0.07%) S&P 500
5,222.68 +94.89 (+1.85%) Dow
39,512.84 +837.14 (+2.16%) Nasdaq
16,340.87 +184.57 (+1.14%) Bitcoin USD
61,361.64 +438.34 (+0.72%) CMC Crypto 200
1,268.12 -44.51 (-3.39%)
GSK Aug 2024 41.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:25PM EDT. Market open.
| Previous close | 4.3000 |
| Open | 4.7200 |
| Bid | 4.0000 |
| Ask | 4.9000 |
| Strike | 41.00 |
| Expiry date | 2024-08-16 |
| Day's range | 4.7200 - 4.7200 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.4k |
Simply Wall St.GSK plc (LON:GSK) Stock Goes Ex-Dividend In Just Four Days
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see GSK plc...
- Simply Wall St.
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
GSK plc's ( LON:GSK ) investors are due to receive a payment of £0.15 per share on 11th of July. The dividend yield...
GlobeNewswireBioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosisGSK to participate in Series C Extension with equity investmentSeries C financing round extended overall by CHF 12.3 million to CHF 44.9 million BASEL, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections
© 2024 Yahoo. All rights reserved.